Difference between revisions of "Burnett JP, et al. Cancer Lett. (2017) cited as Ref 302 in DOI: 10.1038/s41392-020-0110-5 (Q9565)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 28254410, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 52-64, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2017
Timestamp+2017-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2017 / rank
 +
Normal rank
Property / Published In Name String
 +
Cancer Lett.
Property / Published In Name String: Cancer Lett. / rank
 +
Normal rank
Property / Volume
 +
394
Property / Volume: 394 / rank
 +
Normal rank
Property / title
 +
Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells (English)
Property / title: Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells (English) / rank
 +
Normal rank
Property / Page(s)
 +
52-64
Property / Page(s): 52-64 / rank
 +
Normal rank

Latest revision as of 15:37, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Burnett JP, et al. Cancer Lett. (2017) cited as Ref 302 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Burnett JP
    0 references
    0 references
    2017
    0 references
    Cancer Lett.
    0 references
    394
    0 references
    Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells (English)
    0 references
    52-64
    0 references